Ennature Bio Pharma Limited (ENNATURE) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Ennature Bio Pharma Limited on NSE and BSE, with an AI summary of each filing.
ENNATURE BIO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 12-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation 路 12 Nov 2026, 5:30 am
ENNATURE BIO PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 12-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation 路 12 Nov 2026, 5:30 am
To consider and approve the financial results for the period ended September 30, 2026
Intimation 路 12 Nov 2026, 5:30 am
Ennature Bio Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve Please refer attachment
Intimation 路 12 Nov 2026, 5:30 am
Ennature Bio Pharma Schedules Board Meeting for Q2 FY27 Financial Results Ennature Bio Pharma Limited will hold a Board of Directors meeting on 12th Nov'26 to consider and approve the company's unaudited financial results for the quarter ended 30th Sep'26. In accordance with its Code of Conduct for insider trading regulations, the trading window for dealing in company securities remains closed from 4th Nov'26 through 14th Nov'26 (both days inclusive).